When time means life or death for patients with serious diagnoses, eHealth Technologies™ drives powerful digital solutions that advance the delivery of life-altering care. By quickly retrieving, organizing, and aggregating medical information, pathology reports, and images from disparate systems into searchable digital medical records Read More
Featured News
LG ELECTRONICS AND AMWELL PARTNER ON DIGITAL HEALTH INNOVATIONS
Global innovator LG Electronics and telehealth leader Amwell® have joined forces to expand the boundaries of virtual care. By combining LG’s broad innovation portfolio with Amwell’s deep digital health care experience, the two companies plan to jointly develop new device-based service solutions designed to make it easier for patients to […]
CLEARSENSE AND LEIDOS WORK TOGETHER TO TRANSFORM HEALTHCARE DATA
Clearsense®, a technology company that helps healthcare organizations realize measurable value from their data, announced that their firm has entered into a long-term strategic agreement with Leidos, a FORTUNE® 500 science and technology leader. The collaboration will provide healthcare organizations with a complete end-to-end managed services suite combined with cutting-edge […]
Rakuten Medical Announces New Name “Alluminox™” for its Proprietary Technology Platform
Rakuten Medical, Inc. (Rakuten Medical) has elected to discontinue use of the name “Illuminox,” and to start using a new, evolved name “Alluminox™” for our proprietary, anti-cancer, photoimmunotherapy technology platform, which is comprised of drug, medical device, and other related technologies. This name change will take effect globally from April […]
LumiThera, Inc. Announces Completion of Acquisition of Diopsys, Inc
LumiThera Inc., a medical technology company offering photobiomodulation (PBM) to treat eye injuries and diseases, today announced it has completed the acquisition of Diopsys, Inc., a leading provider of advanced medical Visual electrophysiology devices that help ophthalmologists analyze the entire visual pathway for visual and neuro-visual disorders. Diopsys is now a […]
MIM SureCalc® MonteCarlo Selected by Stanford Health Care for Accuray CyberKnife® Plan Second Check
MIM Software Inc. announced today that MIM SureCalc MonteCarlo has been selected for implementation by Stanford Health Care to perform second check for Accuray CyberKnife plans. MIM SureCalc MonteCarlo gives access to an advanced Monte Carlo algorithm powered by SciMoCa™ and next-generation plan second check capabilities to aid patient replanning […]
GLEAMER Receives FDA Clearance for Its Artificial Intelligence Software to Help Detect and Localize Fractures
GLEAMER, a French medtech company pioneering the use of artificial intelligence technology in the practice of radiology, announced today that the United States Food and Drug Administration has cleared its BoneView® AI software for use by U.S. healthcare specialists to aid in diagnosing fractures and traumatic injuries on X-rays. In […]
Accenture and Microsoft to Assist Mount Sinai Health System on Five-Year Transformation Journey to Cloud
Accenture will collaborate with New York City’s largest academic medical system to help devise and securely execute its strategic cloud migration of clinical applications, including its Epic electronic health records system. Microsoft will provide quality assurance throughout this landmark academic center’s Azure migration process. Read More
Faron Obtains Debt Funding from IPF Partners
Faron Pharmaceuticals Ltd. (AIM: FARN) (First North: FARON), a clinical stage biopharmaceutical company focused on building the future of immunotherapy by harnessing the power of the immune system to tackle cancer and inflammation, announces that it has entered into a secured debt agreement (“Funding Agreement”) with IPF Partners (“IPF”) to […]
Hansa Biopharma announces positive early access decision by French Haute Autorité de Santé to use Idefirix® (imlifidase) as desensitization treatment for highly sensitized kidney transplant patients
LUND, Sweden, Feb. 26, 2022 /PRNewswire/ — Hansa Biopharma AB, “Hansa” (Nasdaq Stockholm: HNSA), the pioneer in enzyme technology for rare immunological conditions, today announces that its first-in-class treatment Idefirix® (imlifidase) has been granted early access post marketing authorization (Autorisation d’accès précoce) in France by French HAS (Haute Autorité de […]
